CD40 induces anti-toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 2002-2011

  Van Grol, Jennifer ^a   Muniz Feliciano, Luis ^a   Portillo, Jose Andres C ^a   Bonilha, Vera L ^b   Subaustea, Carlos S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 7; BECLIN 1; CD40 ANTIGEN; LC3 II PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ENZYME; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL KILLING; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; LYSOSOME; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PARASITE LOAD; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTIGENS, CD40; AUTOPHAGY; CELL LINE; ENDOTHELIAL CELLS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICE; RETINAL PIGMENT EPITHELIUM; TOXOPLASMA;

EID: 84877814625     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01145-12     Document Type: Article

References (81)

1. Clark EA, Ledbetter J. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. U. S. A. 83:4494-4498.
2. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669-674.
3. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33-40.
4. Schriever F, Freedman AS, Freeman G, Messner Lee G, Daley J, Nadler LM. 1989. Isolated human follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169:2043-2058.
5. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Aderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82.
6. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J. 11:4313-4321.
7. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594.
8. Graf D, Muller S, Korthauer U, van Kooten C, Weise C, Kroczek RA. 1995. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25:1749-1754.
9. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291-300.
10. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EAM, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, de Vries E, Sanal O, Peitsch MC, Notarangelo LD. 1997. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131:47-54.
11. Winkelstein JA, Marino MC, Ochs HD, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. 2003. The X-linked Hyper-IgM syndrome. Clinical and immunologic features of 79 patients. Medicine 82:373-384.
12. Lazarevic V, Myers AJ, Scanga CA, Flynn JL. 2003. CD40, but not CD40L, is required for optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19:823-835.
13. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. 1996. CD40 ligand is required for protective cellmediated immunity to Leishmania major. Immunity 4:283-289.
14. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ, Ruddle NH, McMahon-Pratt D, Flavell RA. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273.
15. Kamanaka M, Yu P, Yasui T, Yoshida Kawabe T, Horii T, Kishimoto T, Kikutani H. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281.
16. Reichmann G, Walker W, Villegas EN, Craig L, Cai G, Alexander J, Hunter CA. 2000. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect. Immun. 68:1312-1318.
17. Portillo J-AC, Okenka G, Reed E, Subauste A, Van Grol J, Gentil K, Komatsu M, Tanaka K, Landreth G, Levine B, Subauste CS. 2010. The CD40-autophagy pathway is needed for host protection despite IFN-γ- dependent immunity and CD40 induces autophagy via control of p21 levels. PLoS One 5(2):e14472. doi:10.1371/journal.pone.0014472.
18. Cosyns M, Tsirkin S, Jones M, Flavell R, Kikutani H, Hayward AR. 1998. Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect. Immun. 66:603-607.
19. Marriott I, Thomas EK, Bost KL. 1999. CD40-CD40 ligand interactions augment survival of normal mice, but not CD40 ligand knockout mice, challenged orally with Salmonella dublin. Infect. Immun. 67:5253-5257.
20. Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste CS. 2006. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J. Clin. Invest. 116:2366-2377.
21. Desvignes L, Ernst JD. 2009. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31:974-985.
22. Mosa A, Trumstedt C, Eriksson E, Soehnlein O, Heuts F, Janik K, Klos A, Dittrich-Breiholz O, Kracht M, Hidmark A, Wigzell H, Rottenberg ME. 2009. Nonhematopoietic cells control the outcome of infection with Listeria monocytogenes in a nucleotide oligomerization domain 1-dependent manner. Infect. Immun. 77:2908-2918.
23. Andonegui G, Zhou H, Bullard D, Kelly MM, Mullaly SC, McDonald B, Long EM, Robbins SM, Kubes P. 2009. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gramnegative bacterial infection. J. Clin. Invest. 119:1921-1930.
24. Joiner KA, Fuhrman SA, Mietinnen H, Kasper LH, Mellman I. 1990. Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor transfected fibroblasts. Science 249:641-646.
25. Mordue DG, Sibley LD. 1997. Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanisms of entry. J. Immunol. 159:4452-4459.
26. Coppens I, Dunn JD, Romano JD, Pypaert M, Zhang H, Boothroyd JC, Joiner KA. 2006. Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell 125:261-274.
27. Subauste CS, Wessendarp M, Sorensen RU, Leiva L. 1999. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type-1 immune response which can be restored by soluble CD40L trimer. J. Immunol. 162:6690-6700.
28. Hayward AR, Cosyns M, Jones M, Ponnuraj EM. 2001. Marrow-derived CD40 positive cells are required for mice to clear a Cryptosporidium parvum infection. Infect. Immun. 69:1630-1634.
29. Cook-Mills JM, Gallagher JS, Feldbush TL. 1996. Isolation and characterization of high endothelial cell lines derived from mouse lymph nodes. In vitro Cell. Dev. Biol. Anim. 32:167-177.
30. Nandrot EF, Kim Y, Brodie SE, Huang X, Sheppard D, Finnemann SC. 2004. Loss of synchromized retinal phagocytosis and age-related blindness in mice lacking αvβ 5 integrin. J. Exp. Med. 200:1539-1545.
31. Andrade RM, Wessendarp M, Portillo Yang J-ACJQ, Gomez FJ, Durbin JE, Bishop GA, Subauste CS. 2005. TRAF6 signaling downstream of CD40 primes macrophages to acquire anti-microbial activity in response to TNF-α. J. Immunol. 175:6014-6021.
32. Kanuga N, Winton HL, Beauchene L, Koman A, Zerbib A, Halford S, Couraud PO, Keegan D, Coffey P, Lund RD, Adamson P, Greenwood J. 2002. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest. Ophthalmol. Vis. Sci. 43:546-555.
33. Hsing Y, Hostager BS, Bishop GA. 1997. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J. Immunol. 159:4898-4906.
34. Kimura S, Noda T, Yoshimori T. 2007. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescenttagged LC3. Autophagy 3:452-460.
35. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ. 2004. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304:1500-1502.
36. Gubbels MJ, Li C, Striepen B. 2003. High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Antimicrob. Agents Chemother. 47:309-316.
37. McKee AS, Dzierszinski F, Boes M, Roos DS, Pearce EJ. 2004. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J. Immunol. 173:2632-2640.
38. Gubbels MJ, Striepen B, Shastri N, Turkoz M, Robey EA. 2005. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect. Immun. 73:703-711.
39. Andrade RM, Wessendarp M, Subauste CS. 2003. CD154 activates macrophage anti-microbial activity in the absence of IFN-γ through a TNF- α-dependent mechanism. J. Immunol. 171:6750-6756.
40. Portillo J-AC, Van Grol J, Zheng L, Okenka G, Gentil K, Garland A, Carson EC, Kern TS, Subauste CS. 2008. CD40 mediates retinal inflammation and neuro-vascular degeneration. J. Immunol. 181:8719-8726.
41. Bajorath J, Seyama K, Nonoyama S, Ochs HD, Aruffo A. 1996. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Sci. 5:531-534.
42. Lachenmaier SM, Deli MA, Meissner M, Liesenfeld O. 2011. Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J. Neuroimmunol. 232:119-130.
43. Dimier JH, Bout DT. 1993. Co-operation of interleukin-1 β and tumour necrosis factor-α in the activation of human umbilical vein endothelial cells to inhibit Toxoplasma gondii replication. Immunology 79:336-338.
44. + T cell adhesion to endothelium. J. Neuroimmunol. 134:166-178.
45. Tedesco RC, Smith RL, Corte-Real S, Calabrese KS. 2004. Ocular toxoplasmosis: the role of retinal pigment epithelium migration in infection. Parasitol. Res. 92:467-472.
46. Liang XH, Jackson S, Seaman M, Brown KD, Kempkes B, Hibshoosh H, Levine B. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672-676.
47. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728.
48. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. 1998. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23:33-42.
49. Carruthers VB, Sibley D. 1997. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur. J. Cell Biol. 73:114-123.
50. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC. 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1:187-201.
51. Rau SJ, Hildt E, Himmelsbasch K, Thimme R, Wakita T, Blum HE, Fischer R. 2013. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by JNK activation independent from the interferon pathway. Hepatology 57:23-26.
52. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A. 1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158:977-983.
53. Ruby J, Bluethmann H, Aguet M, Ramshaw IA. 1995. CD40 ligand has potent antiviral activity. Nat. Med. 1:437-441.
54. Fine KL, Metcalfe MG, White ES, Virji M, Karls RK, Quinn FD. 2012. Involvement of the autophagy pathway in trafficiking of Mycobacterium tuberculosis bacilli through cultured human type II epithelial cells. Cell. Microbiol. 14:1402-1414.
55. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, Nara A, Funao J, Nakata M, Tsuda K, Hamada S, Yoshimori T. 2004. Autophagy defends cells against invading Group A Streptococcus. Science 306:1037-1040.
56. Ogawa M, Yoshimori T, Suzuki T, Sagara H, Mizushima N, Sasakawa C. 2005. Escape of intracellular Shigella from autophagy. Science 307:727-731.
57. Mostowy S, Sancho-Shimizu V, Hamon MA, Simeone R, Brosch R, Johansen T, Cossart P. 2011. p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways. J. Biol. Chem. 286:26987-26995.
58. Yoshikawa Y, Ogawa M, Hain T, Yoshida M, Fukumatsu M, Kim M, Mimuro H, Nakagawa I, Yanagawa T, Ishii T, Kakizuka A, Sztul E, Chakraborty T, Sasakawa C. 2009. Listeria monocytogenes ActAmediated escape from autophagic recognition. Nat. Cell Biol. 11:1233-1240.
59. Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH. 2006. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281:11374-11383.
60. Thurston TLM, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. 2009. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat. Immunol. 10:1215-1221.
61. Talloczy Z, Virgin HW, Levine B. 2006. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2:24-29.
62. Talloczy Z, Jiang W, Virgin HW, Leib DA, Scheuner D, Kaufman RJ, Eskelinen EL, Levine B. 2002. Regulation of starvation- and virusinduced autophagy by the eIF2α signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 99:190-195.
63. Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, Zhang W, Burns D, Leib DA, Levine B. 2007. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1:23-35.
64. Yap G, Sher A. 1999. Effector cells of both nonhematopoietic and hematopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189:1083-1091.
65. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. 2006. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107:309-316.
66. Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A. 2006. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell. Microbiol. 8:1611-1623.
67. Lambert H, Barragan A. 2010. Modelling parasite dissemination: host cell subversion and immune evasion by Toxoplasma gondii. Cell. Microbiol. 12:292-300.
68. Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan CC. 1994. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp. Parasitol. 78:217-229.
69. Nicholson DH, Wolchok EB. 1976. Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy. Arch. Ophthalmol. 94:248-254.
70. Inoue J, Nishiumi S, Fujishima Y, Masuda A, Shiomi H, Yamamoto K, Nishida M, Azuma T, Yoshida M. 2012. Autophagy in the intestinal epithelium regulates Citrobacter rodentium infection. Arch. Biochem. Biophys. 521:95-101.
71. Woodman JP, Dimier IH, Bout DT. 1991. Human endothelial cells are activated by IFN-γ to inhibit Toxoplasma gondii replication. J. Immunol. 147:2019-2023.
72. Daubener W, Spors B, Hucke C, Adam R, Stins M, Kim KS, Schroten H. 2001. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect. Immun. 69:6527-6531.
73. Pfefferkorn ER. 1984. Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc. Natl. Acad. Sci. U. S. A. 81:908-912.
74. Daubener W, Pilz K, Seghrouchni-Zennati S, Bilzer T, Fischer HG, Hadding U. 1993. Induction of toxoplasmostasis in a human glioblastoma by interferon γ. J. Neuroimmunol. 43:31-38.
75. Daubener W, Remscheid C, Nockemann S, Pilz K, Seghouchni S, Mackenzie C, Hadding U. 1996. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha. Eur. J. Immunol. 26:487-492.
76. Melzer T, Duffy A, Weiss LM, Halonen SK. 2008. The gamma interferon (IFN-γ)-inducible GTP-binding protein IGTP is necessary for Toxoplasma vacuolar disruption and induces parasite egression in IFN-γ- stimulated astrocytes. Infect. Immun. 76:4883-4894.
77. Dimier I, Bout D. 1993. Rat intestinal epithelial cell line IEC-6 is activated by recombinant interferon-γ to inhibit replication of the coccidian Toxoplasma gondii. Eur. J. Immunol. 23:981-983.
78. Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ. 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64: 4188-4196.
79. Halonen SK. 2009. Role of autophagy in the host defense against Toxoplasma gondii in astrocytes. Autophagy 5:268-269.
80. Zhao Z, Fux B, Goodwin M, Dunay R, Strong D, Miller BC, Cadwell K, Delgado MA, Ponpuak M, Green KG, Schmidt RE, Mizushima N, Deretic V, Sibley LD, Virgin HW. 2008. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4:458-469.
81. Willermain F, Caspers-Velu L, Baudson N, Dubois C, Hamdane M, Willems F, Velu T, Bruyns C. 2000. Role and expression of CD40 on human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41: 3485-3491.